StageZero Life Sciences Ltd. (SZLSF)
OTCMKTS
· Delayed Price · Currency is USD
0.0240
-0.0024 (-9.27%)
Jun 25, 2025, 3:14 PM EDT
StageZero Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2013 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2013 - 2017 |
| 2.88 | 3.8 | 5.07 | 4.15 | 0.14 | 0.19 | Upgrade
| |
Revenue Growth (YoY) | -37.63% | -25.12% | 22.07% | 2893.29% | -25.38% | -54.85% | Upgrade
|
Cost of Revenue | 2.85 | 4.2 | 3.89 | 3.46 | 1.1 | 1.09 | Upgrade
|
Gross Profit | 0.03 | -0.4 | 1.18 | 0.7 | -0.96 | -0.91 | Upgrade
|
Selling, General & Admin | 4.48 | 6.99 | 8.37 | 4.21 | 3.93 | 3.76 | Upgrade
|
Research & Development | 0.1 | 0.35 | 0.77 | 0.22 | - | - | Upgrade
|
Operating Expenses | 4.58 | 7.34 | 9.14 | 4.43 | 3.99 | 3.76 | Upgrade
|
Operating Income | -4.55 | -7.75 | -7.96 | -3.74 | -4.95 | -4.67 | Upgrade
|
Interest Expense | -0.39 | -0.28 | -0.2 | -0.66 | -0.75 | -0.47 | Upgrade
|
Currency Exchange Gain (Loss) | - | - | - | - | -0.19 | - | Upgrade
|
Other Non Operating Income (Expenses) | -0.18 | 2.18 | 2.58 | -1.4 | 2.41 | 1.45 | Upgrade
|
EBT Excluding Unusual Items | -5.12 | -5.85 | -5.59 | -5.8 | -3.48 | -3.69 | Upgrade
|
Merger & Restructuring Charges | - | - | -1.24 | - | - | - | Upgrade
|
Impairment of Goodwill | -7.36 | -7.36 | - | - | - | - | Upgrade
|
Other Unusual Items | -0.05 | 1.8 | -0.66 | -1.07 | - | - | Upgrade
|
Pretax Income | -12.53 | -11.42 | -7.48 | -6.86 | -3.48 | -3.69 | Upgrade
|
Net Income | -12.53 | -11.42 | -7.48 | -6.86 | -3.48 | -3.69 | Upgrade
|
Net Income to Common | -12.53 | -11.42 | -7.48 | -6.86 | -3.48 | -3.69 | Upgrade
|
Shares Outstanding (Basic) | 103 | 99 | 71 | 45 | 26 | 17 | Upgrade
|
Shares Outstanding (Diluted) | 103 | 99 | 71 | 45 | 26 | 17 | Upgrade
|
Shares Change (YoY) | 32.99% | 40.60% | 57.77% | 69.14% | 54.89% | 41.63% | Upgrade
|
EPS (Basic) | -0.12 | -0.11 | -0.11 | -0.15 | -0.13 | -0.22 | Upgrade
|
EPS (Diluted) | -0.12 | -0.11 | -0.11 | -0.15 | -0.13 | -0.22 | Upgrade
|
Free Cash Flow | -0.81 | -3.53 | -9.1 | -3.14 | -4.64 | -3.46 | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.04 | -0.13 | -0.07 | -0.17 | -0.20 | Upgrade
|
Gross Margin | 1.04% | -10.64% | 23.23% | 16.75% | - | - | Upgrade
|
Operating Margin | -157.83% | -204.13% | -157.12% | -90.00% | -3567.44% | -2510.83% | Upgrade
|
Profit Margin | -434.85% | -300.79% | -147.67% | -165.32% | -2510.24% | -1986.66% | Upgrade
|
Free Cash Flow Margin | -28.07% | -92.98% | -179.61% | -75.55% | -3341.82% | -1863.54% | Upgrade
|
EBITDA | -4.46 | -7.51 | -7.65 | -3.48 | -4.69 | -4.06 | Upgrade
|
EBITDA Margin | -154.88% | -197.81% | -150.98% | -83.86% | - | - | Upgrade
|
D&A For EBITDA | 0.09 | 0.24 | 0.31 | 0.26 | 0.26 | 0.61 | Upgrade
|
EBIT | -4.55 | -7.75 | -7.96 | -3.74 | -4.95 | -4.67 | Upgrade
|
EBIT Margin | -157.83% | -204.13% | -157.12% | -90.00% | - | - | Upgrade
|
Revenue as Reported | - | - | - | - | - | 0.19 | Upgrade
|
Updated Dec 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.